By Dietrich Knauth NEW YORK (Reuters) -Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to ...

Johnson & Johnson seeks approval for a $10 billion proposal to resolve lawsuits alleging its baby powder caused ovarian ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby ...

Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...

Johnson & Johnson is facing a critical test over its $10B proposal to end litigation alleging that its baby powder caused ovarian cancer, ...

Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to force an end to all related cancer lawsuits. The proposed settlement ...

Our clients are passing away,” attorney James Onder told US Bankruptcy Judge Christopher Lopez on Tuesday, the start of a ...

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal health agencies' payments of medical costs for patients who allege that the ...

Two U.S. federal health agencies have objected to Johnson & Johnson's $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in bankruptcy ...

Johnson & Johnson faces a critical test on Tuesday (February 18) over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to ...

The judge will listen to supporters and opponents of J&J's bankruptcy proposal in a marathon court hearing that will last ...

Courts have rejected the company’s two previous efforts to resolve the talc litigation through a subsidiary’s bankruptcy.